DIONNE et al v. LIOTTA et al - Page 10




          Interference No. 103,906                                                      


          § 112 requires that the scope of the claims must bear a                       
          reasonable correlation to the scope of enablement provided by the             
          specification to persons of ordinary skill in the art.  Also, the             
          scope of enablement varies inversely with the degree of                       
          unpredictability in the art.  Wright, 999 F.2d at 1561, 27 USPQ2d             
          at 1513; In re Vaeck, 947 F.2d 488, 495, 20 USPQ2d 1438, 1444                 
          (Fed. Cir. 1991); Amgen Inc. v. Chugai Pharm. Co., 927 F.2d 1200,             
          1214, 18 USPQ2d 1016, 1028 (Fed. Cir. 1991); In re Angstadt, 537              
          F.2d at 501-02, 190 USPQ at 217-18; In re Fisher, 427 F.3d 833,               
          839, 166 USPQ 18, 24 (CCPA 1970).                                             
               Moreover, to be enabling, the specification of a patent must             
          teach those skilled in the art how to make and use the full scope             
          of the claimed invention without “undue experimentation.”                     
          Factors which may be considered in determining whether a                      
          disclosure would require undue experimentation are:                           
               (1) the quantity of experimentation necessary,                           
               (2) the amount of direction or guidance presented,                       
               (3) the presence or absence of working examples,                         
               (4) the nature of the invention, (5) the state of                        
               the prior art, (6) the relative skill of those in                        
               the art, (7) the predictability or unpredictability                      
               of the art, and (8) the breadth of the claims.                           
          Enzo Biochem, Inc., v. Calgene, Inc., 188 F.3d 1362, 1371-74, 52              
          USPQ2d 1129, 1135-38 (Fed. Cir. 1999).                                        
               Based upon the foregoing principles of law, we agree with                

                                          10                                            





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007